Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0247421 NUCLEOTIDE SEQUENCES, VECTORS AND HOST CELLS
Polynucleotides encoding fusion proteins comprising fragments of toxin A and toxin B from Clostridium difficile are described, as well as vectors and host...
2017/0247420 PREVENTION, TREATMENT AND DIAGNOSIS OF P.GINGIVALIS INFECTION
The invention relates to generation and use of cellular and humoral responses for the prevention and treatment of P. gingivalis related conditions and diseases.
2017/0247419 Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor
The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.
2017/0247418 EBOLAVIRUS PRE-HAIRPIN INTERMEDIATE MIMICS AND METHODS OF USE
Ebolavirus is a highly lethal filovirus that causes hemorrhagic fever in humans and non-human primates. With no approved treatments or preventatives, the...
2017/0247417 T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
The present invention concerns compositions and methods of use of T-cell redirecting complexes, with at least one binding site for a T-cell antigen and at...
2017/0247416 Peptide with Safer Secondary Structure, Peptide Library, and Production Methods for Same
An object of the invention is to provide a peptide having a stabilized secondary structure. The present invention provides a peptide having a secondary structure ...
2017/0247415 ENGINEERING THE PRODUCTION OF A CONFORMATIONAL VARIANT OF OCCIDIOFUNGIN THAT HAS ENHANCED INHIBITORY ACTIVITY...
Occidiofungin is a cyclic nonribosomally synthesized antifungal peptide with submicromolar activity. This invention is directed to compositions enriched for...
2017/0247414 ANTI-MICROBIAL PEPTIDES
Described herein are anti-microbial peptides having enhanced activity and transport.
2017/0247413 COMPSTATIN ANALOGS WITH IMPROVED PHARMACOKINETIC PROPERTIES
Compounds comprising peptides capable of binding C3 protein and inhibiting complement activation are disclosed. The compounds comprise compstatin analogs in...
2017/0247412 TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES
Compounds and compositions are disclosed in which a quaternized drug unit is linked to a targeting ligand unit from which a tertiary amine-containing drug is...
2017/0247411 PEPTIDE HAVING OSTEOGENIC DIFFERENTIATION PROMOTION AND PERIODONTAL LIGAMENT FIBROBLAST ACTIVATION PROMOTION,...
A peptide comprising an amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2, according to the present invention, shows proliferation and differentiation...
2017/0247410 ANTIBACTERIAL ANTISENSE OLIGONUCLEOTIDE AND METHOD
A method for enhancing, by at least 10 fold, the antibacterial activity of an antisense oligonucleotide composed of morpholino subunits linked by ...
2017/0247409 ABIETANE-TYPE DITERPENOIDS
The present invention relates to the field of wood rosin and resin acid derivatives and more particularly to abietane-type diterpenoids as well as different...
2017/0247408 CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME
Compounds having cytotoxic and/or anti-mitotic activity are disclosed. Methods associated with preparation and use of such compounds, as well as pharmaceutical...
2017/0247407 AFFINITY CHROMATOGRAPHY MATRIX
The invention discloses a polypeptide capable of binding immunoglobulins or immunoglobulin-containing proteins, which polypeptide comprises six or more domains...
2017/0247406 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
Described herein are steroids of Formula (I): and pharmaceutically acceptable salts thereof; wherein R.sup.1, R.sup.2a, R.sup.2b, R.sup.3, R.sub.4, R.sup.5a,...
2017/0247405 OXYSTEROLS AND METHODS OF USE THEREOF
Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein X, Y, R.sup.1,...
2017/0247404 PROCESS FOR THE PREPARATION OF SOFOSBUVIR
The present invention relates to a process for the synthesis of Sofosbuvir.
2017/0247403 TETRACYCLIC ANTHRAQUINONE DERIVATIVES
Disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof, ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4,...
2017/0247402 HETEROCYCLE-SUBSTITUTED XANTHENE DYES
The present invention relates to fluorescent dyes in general. The present invention provides a wide range of fluorescent dyes and kits containing the same,...
2017/0247401 COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
The present invention encompasses compounds and methods for treating urinary tract infections.
2017/0247400 METFORMIN DERIVATIVES
The present invention relates to novel biguanide derivatives including their pharmaceutically acceptable salts. The invention also relates processes for the...
2017/0247399 PROCESS OF PRODUCING PHOSPHINOTHRICIN EMPLOYING NITRILASES
The present invention generally relates to processes for the enzymatic production of a phosphinothricin product or precursor thereof from a nitrile-containing...
2017/0247398 O-PHENYL CHALCONE COMPOUNDS AND USES THEREOF
Disclosed are an o-phenyl chalcone compounds and preparation methods and uses thereof. The o-phenyl chalcone compounds are capable of inhibiting the...
2017/0247397 PYRIDINE COMPLEX OF ZIRCONIUM, CATALYTIC SYSTEM COMPRISING SAID PYRIDINE COMPLEX OF ZIRCONIUM AND PROCESS OF...
Pyridine complex of zirconium having general formula (I): Said pyridine complex of zirconium having general formula (I) may advantageously be used in a...
2017/0247396 TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE
The present invention provides compounds of Formula (I): wherein A and R.sup.1 are each as defined in the specification, and compositions comprising any of...
2017/0247395 IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR4 (PAR4) INHIBITORS FOR...
The present invention provides thiazole compounds of Formula I wherein W, Y, R.sup.0, R.sup.2, R.sup.4, R.sup.5, R.sup.6, R.sup.7, X.sup.1, X.sup.2, X.sup.3...
2017/0247394 SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
The present invention encompasses compounds of formula (I) wherein the groups R.sup.1 to R.sup.7, A, V, W, X, Y, n, r and q are defined in claim 1, their use...
2017/0247393 Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
The present invention relates to novel aminoisoxazoline compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial...
2017/0247392 ALK KINASE INHIBITOR, AND PREPARATION METHOD AND USES THEREOF
An ALK kinase inhibitor compound as represented by Formula I, pharmaceutical composition containing the compound, and preparation method and use thereof in the...
2017/0247391 THIENOPYRIMIDINE AND THIENOPYRIDINE COMPOUNDS AND METHODS OF USE THEREOF
The present disclosure provides compounds and methods for inhibiting the interaction of menin with its upstream or downstream signaling molecules including but...
2017/0247390 P38 MAP KINASE INHIBITING INDANYL UREA COMPOUNDS
The present invention relates to novel indanyl urea derivatives, their pharmaceutically acceptable salts, and their isomers, stereoisomers, atropisomers,...
2017/0247389 SHIP1 MODULATORS AND METHODS RELATED THERETO
Compounds of formula (II): ##STR00001## wherein ##STR00002## R.sup.1, R.sup.2, R.sup.5 and R.sup.13 are described herein, or a stereoisomer, enantiomer or...
2017/0247388 INHIBITORS OF IRAK4 ACTIVITY
The present invention relates to inhibitors of IRAK4 of Formula I and provides compositions comprising such inhibitors, as well as methods therewith for...
2017/0247387 UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF
Disclosed are compounds that may be used to inhibit the action of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL) or dual FAAH/MAGL.
2017/0247386 SOLID FORMS OF AN ANTIVIRAL COMPOUND
Crystalline solid forms of methyl {(2S)-1-[(2S,5S)-2-(9-{2-[(2S,4S)-1-{(2R)-2-[(methoxycarbonyl)amino]-2-ph- ...
2017/0247385 FUROPYRIDINE COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
Compounds of formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against...
2017/0247384 CONJUGATES OF PORPHYRINOID PHOTOSENSITIZERS AND GLYCEROL-BASED POLYMERS FOR PHOTODYNAMIC THERAPY
Biologically active compounds that can be used as photosensitizers for diagnostic and therapeutic applications, particularly for PDT of cancer, infections and...
2017/0247383 NEUROACTIVE COMPOUNDS AND METHODS OF USING THE SAME
The invention described herein relates generally to neuroactive compounds and compositions for the treatment psychotic disorders, methods for treating...
2017/0247381 DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE
The invention relates generally to pharmaceutical tablet compositions comprising fumaric acid and the compound ...
2017/0247380 METHOD FOR PREPARING PALBOCICLIB
This invention reveals the method for preparing Palbociclib (I). The preparation includes: produce the ...
2017/0247379 METHOD FOR PREPARING PALBOCICLIB
The invention discloses a method for preparing Palbociclib (I). The preparation method comprises the steps of: causing a ring-closing reaction of...
2017/0247378 IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS
The compounds of formula (I) are inhibitors of SSAO activity ##STR00001## wherein V, W, X, Y, Z, R.sup.1 and R.sup.2 are as defined in the claims.
2017/0247377 DIAZINE-FUSED AMIDINES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE
In its many embodiments, the present invention provides certain C-6 spirocarbocyclic iminothiadiazine compounds, including compounds Formula (I) or a tautomer...
2017/0247376 METHODS AND COMPOSITIONS FOR INHIBITION OF RAS
Inhibitors of Ras protein, methods to modulate the activity of Ras protein, and methods of treatment of disorders mediated by Ras protein are provided. A...
2017/0247375 PYRAZOLOPYRIDINE DERIVATIVES AND THEIR USE IN THERAPY
The present invention relates to pyrazolopyridine derivatives, which are useful as medicaments, pharmaceutical compositions comprising one or more of the...
2017/0247374 CaMKII INHIBITORS AND USES THEREOF
The present invention provides compounds useful as inhibitors of Ca.sup.2+/calmodulin-dependent protein kinase (CaMKII), compositions thereof, and methods of...
2017/0247373 TYK2 INHIBITORS AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated...
2017/0247372 PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES
The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl and pyrrolo[2,3-d]pyridinyl acrylamides and analogues thereof. Such compounds...
2017/0247371 ONE CLASS OF PYRAZOLONE COMPOUNDS AND USE THEREOF
Provided are a class of pyrazolone compounds and a use thereof. In particular, a compound represented by formula I is provided, wherein the definition of each...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.